GlassScriptPhysician profile
Milana Turner
NPI 1407237191
$3,892.23
in general payments reported to CMS, 2019-2025
33 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,700 · 2020: $437 · 2021: $338 · 2022: $276 · 2023: $385 · 2024: $485 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,141.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,156.47 | 2019-2024 | Bun-Yo-Matic |
| Stryker Corporation | $511.37 | 2019-2025 | Citrefix, Regenkit-Tht, Viaflow |
| Arthrex, INC. | $306.36 | 2019 | |
| Smith+Nephew, INC. | $239.03 | 2019-2020 | |
| Kci USA, INC. | $173.37 | 2019-2020 | |
| Mimedx Group, INC. | $153.66 | 2024-2025 | |
| Nevro Corp. | $150.26 | 2020-2023 | Senza |
| Bioventus LLC | $128.06 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Cardiovascular Systems INC. | $123.21 | 2020 | |
| Pinnacle, INC | $103.34 | 2019-2023 | |
| Wright Medical Technology, INC. | $94.13 | 2019 | |
| Abbvie INC. | $74.50 | 2022-2025 | |
| Anika Therapeutics, INC. | $72.44 | 2024 | Toe Motion, Integrity, Tactoset |
| Treace Medical Concepts, INC. | $56.51 | 2023-2025 | |
| Organogenesis INC. | $52.71 | 2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $51.32 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Orthofix Medical, INC. | $51.02 | 2020-2023 | Physio-Stim |
| Amgen INC. | $43.31 | 2025 | Krystexxa |
| Globus Medical, INC. | $38.98 | 2025 | Senza |
| Zimmer Biomet Holdings, INC. | $36.18 | 2020-2021 | |
| Merz Pharmaceuticals, LLC | $32.10 | 2024 | Xeomin |
| Surgenex LLC | $31.60 | 2025 | Renograft, Surgraft, Pellograft |
| Medline Industries LP | $29.50 | 2021 | |
| Convatec INC. | $28.02 | 2023 | |
| Biopro, INC. | $21.91 | 2019 | |
| Heron Therapeutics, INC. | $21.32 | 2022 | |
| Averitas Pharma INC. | $19.78 | 2023 | Qutenza |
| Biotissue Holdings INC. | $18.64 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $17.48 | 2025 | |
| Linvatec Corporation | $16.04 | 2021 | |
| Becton, Dickinson and Company | $14.75 | 2019 | |
| Grt US Holding, INC. | $12.88 | 2021 | |
| Integra Lifesciences Corporation | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milana Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.